Clinical trial
Evaluation of the PCL Rapid Point of Care Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2
NCT04403906 is registered in ClinicalTrials.gov with Somerset NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the PCL Rapid Point of Care Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2
- Lead sponsor
- Somerset NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2020
- Completion date
- August 31, 2021
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid, sars-cov 2